Tower Research Capital LLC (TRC) - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$9,000
-62.5%
20,621
-43.4%
0.00%
-66.7%
Q4 2016$24,000
+100.0%
36,413
+1296.7%
0.00%
+50.0%
Q4 2015$12,000
+20.0%
2,607
+55.6%
0.00%
+100.0%
Q3 2015$10,000
-86.7%
1,675
-80.6%
0.00%
-85.7%
Q2 2015$75,0008,656
+2738.0%
0.01%
Q4 2014$0305
+93.0%
0.00%
Q4 2013$01580.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Sio Capital Management, LLC 2,535,564$7,835,0004.00%
ProQuest Associates IV LLC 1,900,000$5,871,0002.39%
Abingworth LLP 437,994$1,349,0001.41%
Hilltop Park Associates LLC 75,000$232,0000.97%
Broadfin Capital, LLC 1,154,674$3,568,0000.35%
Perceptive Advisors 1,492,156$4,611,0000.32%
Rhenman & Partners Asset Management AB 300,000$927,0000.16%
Rock Springs Capital Management LP 450,000$1,391,0000.10%
WEXFORD CAPITAL LP 145,622$450,0000.08%
BOOTHBAY FUND MANAGEMENT, LLC 15,960$49,0000.02%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders